400 related articles for article (PubMed ID: 19389064)
1. Enzymatic characterisation of clinical isolates of Cryptococcus neoformans, Cryptococcus gattii and other environmental Cryptococcus spp.
Chan MY; Tay ST
Mycoses; 2010 Jan; 53(1):26-31. PubMed ID: 19389064
[TBL] [Abstract][Full Text] [Related]
2. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil.
Andrade-Silva L; Ferreira-Paim K; Mora DJ; Da Silva PR; Andrade AA; Araujo NE; Pedrosa AL; Silva-Vergara ML
Med Mycol; 2013 Aug; 51(6):635-40. PubMed ID: 23343452
[TBL] [Abstract][Full Text] [Related]
4. Environmental isolation of Cryptococcus neoformans and Cryptococcus gattii from living trees in Guindy National Park, Chennai, South India.
Girish Kumar CP; Prabu D; Mitani H; Mikami Y; Menon T
Mycoses; 2010 May; 53(3):262-4. PubMed ID: 19389069
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas.
Andrade-Silva L; Ferreira-Paim K; Silva-Vergara ML; Pedrosa AL
Fungal Biol; 2010; 114(5-6):438-45. PubMed ID: 20943154
[TBL] [Abstract][Full Text] [Related]
6. Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update.
Chowdhary A; Rhandhawa HS; Prakash A; Meis JF
Crit Rev Microbiol; 2012 Feb; 38(1):1-16. PubMed ID: 22133016
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
[TBL] [Abstract][Full Text] [Related]
8. Genotype and mating type analysis of Cryptococcus neoformans and Cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients.
Feng X; Yao Z; Ren D; Liao W; Wu J
FEMS Yeast Res; 2008 Sep; 8(6):930-8. PubMed ID: 18671745
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcus neoformans serotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazole and voriconazole.
Khan ZU; Randhawa HS; Chehadeh W; Chowdhary A; Kowshik T; Chandy R
Int J Antimicrob Agents; 2009 Jun; 33(6):559-63. PubMed ID: 19195846
[TBL] [Abstract][Full Text] [Related]
10. Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.
Kangogo M; Bader O; Boga H; Wanyoike W; Folba C; Worasilchai N; Weig M; Groß U; Bii CC
Mycoses; 2015 Nov; 58(11):665-70. PubMed ID: 26404188
[TBL] [Abstract][Full Text] [Related]
11. Ecological surveys of the Cryptococcus species complex in China.
Li AS; Pan WH; Wu SX; Hideaki T; Guo NR; Shen YN; Lu GX; Pan RG; Zhu MC; Chen M; Shi WM; Liao WQ
Chin Med J (Engl); 2012 Feb; 125(3):511-6. PubMed ID: 22490412
[TBL] [Abstract][Full Text] [Related]
12. Characterization of clinical isolates of the Cryptococcus neoformans-Cryptococcus gattii species complex from the Amazonas State in Brazil.
Da Silva BK; Freire AK; Bentes Ados S; Sampaio Ide L; Santos LO; Dos Santos MS; De Souza JV
Rev Iberoam Micol; 2012; 29(1):40-3. PubMed ID: 21699993
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterisation of clinical Cryptococcus neoformans and Cryptococcus gattii isolates from Sichuan province, China.
Wu SY; Lei Y; Kang M; Xiao YL; Chen ZX
Mycoses; 2015 May; 58(5):280-7. PubMed ID: 25808662
[TBL] [Abstract][Full Text] [Related]
14. [Phenotype characterization of environmental Cryptococcus neoformans isolates].
Huérfano S; Cepero MC; Castañeda E
Biomedica; 2003 Sep; 23(3):328-40. PubMed ID: 14582336
[TBL] [Abstract][Full Text] [Related]
15. Cryptococcus neoformans var. gattii in India.
Padhye AA; Chakrabarti A; Chander J; Kaufman L
J Med Vet Mycol; 1993; 31(2):165-8. PubMed ID: 8509953
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions.
Kwon-Chung KJ; Bennett JE
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Jul; 257(2):213-8. PubMed ID: 6207684
[TBL] [Abstract][Full Text] [Related]
17. Distribution and association between environmental and clinical isolates of Cryptococcus neoformans in Bogotá-Colombia, 2012-2015.
Vélez N; Escandón P
Mem Inst Oswaldo Cruz; 2016 Oct; 111(10):642-648. PubMed ID: 27706379
[TBL] [Abstract][Full Text] [Related]
18. Genotypic diversity of environmental Cryptococcus neoformans isolates from Northern Portugal.
Ferreira AS; Sampaio A; Maduro AP; Silva I; Teles F; Martins Mda L; Inácio J
Mycoses; 2014 Feb; 57(2):98-104. PubMed ID: 23848429
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic characterization of clinical and environmental Cryptococcus neoformans strains isolated in Italy.
Pini G; Faggi E; Campisi E
Rev Iberoam Micol; 2017; 34(2):77-82. PubMed ID: 28215482
[TBL] [Abstract][Full Text] [Related]
20. Method for identification of Cryptococcus neoformans and Cryptococcus gattii useful in resource-limited settings.
Ogundeji AO; Albertyn J; Pohl CH; Sebolai OM
J Clin Pathol; 2016 Apr; 69(4):352-7. PubMed ID: 26598625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
